| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.739 | 0.01 | 0.739 | Analgesic | 0.517 0.044 CID_154699721 | ||
| 0.678 | 0.003 | 0.678 | 5 Hydroxytryptamine uptake inhibitor | 0.256 0.008 CID_154699721 | ||
| 0.675 | 0.005 | 0.675 | Psychostimulant | 0.524 0.009 CID_154699721 | ||
| 0.632 | 0.004 | 0.632 | Calcium channel L-type activator | 0.523 0.02 CID_154699721 | ||
| 0.597 | 0.008 | 0.849 | Vasodilator, coronary | 0.849 0.003 CID_154699721 | CID_154699721 | |
| 0.527 | 0.003 | 0.527 | Adrenaline uptake inhibitor | 0.22 0.005 CID_154699721 | ||
| 0.472 | 0.027 | 0.596 | Spasmolytic | 0.596 0.013 CID_154699721 | CID_154699721 | |
| 0.462 | 0.05 | 0.752 | Transcription factor NF kappa B inhibitor | 0.752 0.016 CID_154699721 | CID_154699721 | |
| 0.428 | 0.02 | 0.54 | Interleukin 2 agonist | 0.54 0.005 CID_154699721 | CID_154699721 | |
| 0.442 | 0.038 | 0.442 | 5 Hydroxytryptamine release stimulant | 0.206 0.116 CID_154699721 | ||
| 0.387 | 0.003 | 0.387 | Adrenaline agonist | |||
| 0.386 | 0.003 | 0.386 | Toll-Like receptor 3 antagonist | 0.247 0.004 CID_154699721 | ||
| 0.427 | 0.047 | 0.427 | Vasodilator, peripheral | 0.334 0.081 CID_154699721 | ||
| 0.385 | 0.007 | 0.385 | Anesthetic local | |||
| 0.393 | 0.02 | 0.572 | Interleukin agonist | 0.572 0.005 CID_154699721 | CID_154699721 | |
| 0.366 | 0.006 | 0.366 | Bronchodilator | 0.113 0.05 CID_154699721 | ||
| 0.385 | 0.031 | 0.385 | Calcium channel activator | |||
| 0.428 | 0.076 | 0.736 | Cyclophilin D inhibitor | 0.736 0.011 CID_154699721 | CID_154699721 | |
| 0.337 | 0.014 | 0.418 | Peptidyltransferase inhibitor | 0.418 0.006 CID_154699721 | CID_154699721 | |
| 0.387 | 0.071 | 0.389 | Antiobesity | 0.389 0.07 CID_154699721 | CID_154699721 | |
| 0.313 | 0.022 | 0.313 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.345 | 0.066 | 0.56 | Cholesterol antagonist | 0.56 0.024 CID_154699721 | CID_154699721 | |
| 0.319 | 0.046 | 0.515 | Antiamyloidogenic | 0.515 0.015 CID_154699721 | CID_154699721 | |
| 0.313 | 0.044 | 0.419 | Vasodilator | 0.419 0.02 CID_154699721 | CID_154699721 | |
| 0.312 | 0.049 | 0.6 | Hypoglycemic | 0.6 0.008 CID_154699721 | CID_154699721 | |
| 0.377 | 0.125 | 0.377 | Caspase 9 stimulant | 0.341 0.153 CID_154699721 | ||
| 0.254 | 0.003 | 0.254 | Beta adrenoreceptor antagonist | 0.062 0.051 CID_154699721 | ||
| 0.25 | 0.004 | 0.25 | Adenylate cyclase stimulant | 0.176 0.03 CID_154699721 | ||
| 0.259 | 0.023 | 0.259 | Acetylcholine M1 receptor antagonist | |||
| 0.314 | 0.079 | 0.674 | Antithrombotic | 0.674 0.01 CID_154699721 | CID_154699721 | |
| 0.28 | 0.046 | 0.28 | Anticonvulsant | |||
| 0.237 | 0.019 | 0.237 | Antiadrenergic | |||
| 0.231 | 0.013 | 0.231 | Alpha 2c adrenoreceptor antagonist | |||
| 0.222 | 0.007 | 0.222 | Nitric-oxide synthase inhibitor | |||
| 0.232 | 0.019 | 0.232 | Adrenaline antagonist | |||
| 0.219 | 0.007 | 0.219 | Inducible nitric-oxide synthase inhibitor | |||
| 0.215 | 0.007 | 0.215 | Sphingomyelinase inhibitor | 0.212 0.008 CID_154699721 | ||
| 0.244 | 0.038 | 0.244 | Insulin sensitizer | 0.22 0.054 CID_154699721 | ||
| 0.208 | 0.003 | 0.208 | Beta 1 adrenoreceptor antagonist | |||
| 0.199 | 0.003 | 0.199 | Beta 2 adrenoreceptor antagonist | |||
| 0.235 | 0.044 | 0.235 | Nitric-oxide synthase stimulant | 0.172 0.147 CID_154699721 | ||
| 0.263 | 0.073 | 0.316 | DNA damaging | 0.316 0.051 CID_154699721 | CID_154699721 | |
| 0.201 | 0.023 | 0.201 | Alpha 2b adrenoreceptor antagonist | |||
| 0.199 | 0.027 | 0.312 | Alkylator | 0.312 0.012 CID_154699721 | CID_154699721 | |
| 0.168 | 0.007 | 0.2 | Glutamate release inhibitor | 0.2 0.005 CID_154699721 | CID_154699721 | |
| 0.171 | 0.013 | 0.171 | Alpha adrenoreceptor agonist | |||
| 0.176 | 0.02 | 0.176 | Mucolytic | 0.136 0.041 CID_154699721 | ||
| 0.217 | 0.062 | 0.217 | Neurotrophic factor enhancer | |||
| 0.163 | 0.01 | 0.163 | Acetylcholine M3 receptor antagonist | |||
| 0.233 | 0.08 | 0.304 | DNA synthesis inhibitor | 0.304 0.042 CID_154699721 | CID_154699721 | |
| 0.176 | 0.026 | 0.176 | Interleukin 1b antagonist | 0.131 0.054 CID_154699721 | ||
| 0.282 | 0.134 | 0.433 | Histamine release inhibitor | 0.433 0.059 CID_154699721 | CID_154699721 | |
| 0.179 | 0.031 | 0.179 | Acetylcholine muscarinic antagonist | |||
| 0.207 | 0.06 | 0.207 | P-glycoprotein inhibitor | 0.204 0.061 CID_154699721 | ||
| 0.168 | 0.023 | 0.168 | Alpha 2 adrenoreceptor antagonist | |||
| 0.238 | 0.093 | 0.238 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.231 | 0.088 | 0.231 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.15 | 0.01 | 0.15 | Dopamine uptake inhibitor | |||
| 0.186 | 0.047 | 0.186 | Protein kinase stimulant | 0.166 0.057 CID_154699721 | ||
| 0.164 | 0.03 | 0.268 | Expectorant | 0.268 0.011 CID_154699721 | CID_154699721 | |
| 0.137 | 0.003 | 0.137 | Beta 2 adrenoreceptor agonist | |||
| 0.171 | 0.038 | 0.171 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.176 | 0.043 | 0.321 | Cell wall synthesis inhibitor | 0.321 0.009 CID_154699721 | CID_154699721 | |
| 0.173 | 0.041 | 0.173 | Cholinergic antagonist | |||
| 0.173 | 0.044 | 0.235 | Alpha-N-acetylglucosaminidase inhibitor | 0.235 0.026 CID_154699721 | CID_154699721 | |
| 0.138 | 0.009 | 0.138 | Acetylcholine M5 receptor antagonist | |||
| 0.168 | 0.041 | 0.168 | Acetylcholine antagonist | |||
| 0.199 | 0.073 | 0.199 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.225 | 0.107 | 0.508 | Immunostimulant | 0.508 0.028 CID_154699721 | CID_154699721 | |
| 0.136 | 0.018 | 0.136 | Glutamate (mGluR7) agonist | |||
| 0.155 | 0.042 | 0.155 | Adenylate cyclase inhibitor | |||
| 0.133 | 0.021 | 0.133 | Protein kinase B gamma inhibitor | |||
| 0.197 | 0.086 | 0.197 | Interleukin antagonist | |||
| 0.12 | 0.01 | 0.12 | Beta 3 adrenoreceptor antagonist | |||
| 0.115 | 0.005 | 0.115 | Glycine transporter 1 inhibitor | |||
| 0.19 | 0.081 | 0.19 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.136 | 0.029 | 0.136 | NMDA receptor antagonist | |||
| 0.144 | 0.045 | 0.144 | Vanilloid 1 agonist | 0.126 0.074 CID_154699721 | ||
| 0.118 | 0.019 | 0.118 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.1 | 0.004 | 0.1 | Beta adrenoreceptor agonist | |||
| 0.101 | 0.01 | 0.128 | Factor IXa inhibitor | 0.128 0.005 CID_154699721 | CID_154699721 | |
| 0.179 | 0.088 | 0.179 | Growth factor agonist | |||
| 0.101 | 0.012 | 0.101 | Dopamine transporter inhibitor | |||
| 0.119 | 0.03 | 0.119 | Acetylcholine nicotinic antagonist | |||
| 0.217 | 0.133 | 0.217 | Hypoxia-inducible factor 1 alpha inhibitor | 0.198 0.154 CID_154699721 | ||
| 0.12 | 0.039 | 0.12 | Anabolic | |||
| 0.097 | 0.016 | 0.097 | Alpha 2 adrenoreceptor agonist | |||
| 0.105 | 0.025 | 0.118 | Interferon agonist | 0.118 0.018 CID_154699721 | CID_154699721 | |
| 0.083 | 0.008 | 0.114 | Adenine nucleotide translocase inhibitor | 0.114 0.004 CID_154699721 | CID_154699721 | |
| 0.11 | 0.039 | 0.166 | Triose-phosphate isomerase inhibitor | 0.166 0.016 CID_154699721 | CID_154699721 | |
| 0.157 | 0.086 | 0.157 | Antipruritic | |||
| 0.118 | 0.048 | 0.118 | Carbonic anhydrase XV inhibitor | |||
| 0.108 | 0.038 | 0.108 | Aminoacyl-tRNA synthetase inhibitor | 0.086 0.066 CID_154699721 | ||
| 0.075 | 0.005 | 0.131 | Cytokine production stimulant | 0.131 0.003 CID_154699721 | CID_154699721 | |
| 0.176 | 0.107 | 0.608 | Angiogenesis stimulant | 0.608 0.006 CID_154699721 | CID_154699721 | |
| 0.166 | 0.098 | 0.166 | Anesthetic general | 0.155 0.108 CID_154699721 | ||
| 0.099 | 0.032 | 0.099 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.102 | 0.035 | 0.102 | Alpha 2a adrenoreceptor antagonist | |||
| 0.103 | 0.041 | 0.103 | Ornithine decarboxylase inhibitor | |||
| 0.075 | 0.014 | 0.112 | Alpha-mannosidase inhibitor | 0.112 0.005 CID_154699721 | CID_154699721 | |
| 0.104 | 0.045 | 0.104 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.111 | 0.051 | 0.111 | Alpha adrenoreceptor antagonist | |||
| 0.102 | 0.043 | 0.102 | Polo-like kinase-1 inhibitor | |||
| 0.081 | 0.023 | 0.09 | Interferon inducer | 0.09 0.017 CID_154699721 | CID_154699721 | |
| 0.088 | 0.03 | 0.088 | Neuronal nicotinic receptor antagonist | |||
| 0.137 | 0.082 | 0.137 | MAP3K9 inhibitor | |||
| 0.218 | 0.164 | 0.218 | Sodium/bile acid cotransporter inhibitor | 0.198 0.191 CID_154699721 | ||
| 0.115 | 0.061 | 0.115 | Nav1.5 sodium channel blocker | |||
| 0.065 | 0.014 | 0.117 | Mannosidase inhibitor | 0.117 0.005 CID_154699721 | CID_154699721 | |
| 0.055 | 0.005 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.046 0.01 CID_154699721 | ||
| 0.101 | 0.053 | 0.101 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.107 | 0.059 | 0.107 | Nav1.1 sodium channel blocker | |||
| 0.168 | 0.12 | 0.277 | Hypolipemic | 0.277 0.056 CID_154699721 | CID_154699721 | |
| 0.089 | 0.042 | 0.089 | Estrogen-related receptor beta agonist | |||
| 0.126 | 0.08 | 0.126 | Interleukin 1 antagonist | |||
| 0.1 | 0.055 | 0.1 | Antihistaminic | |||
| 0.066 | 0.022 | 0.066 | Glycine transporter inhibitor | |||
| 0.104 | 0.061 | 0.104 | Adenylate kinase inhibitor | |||
| 0.149 | 0.108 | 0.149 | Phospholipase C inhibitor | |||
| 0.281 | 0.239 | 0.281 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.111 | 0.07 | 0.111 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.082 | 0.041 | 0.082 | Histidine decarboxylase inhibitor | |||
| 0.085 | 0.044 | 0.085 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.053 | 0.013 | 0.053 | Diamine oxidase inhibitor | |||
| 0.108 | 0.069 | 0.108 | Acetylcholine release stimulant | 0.104 0.078 CID_154699721 | ||
| 0.135 | 0.096 | 0.135 | Ca2+-transporting ATPase inhibitor | 0.134 0.099 CID_154699721 | ||
| 0.088 | 0.05 | 0.088 | mTOR complex 2 inhibitor | |||
| 0.097 | 0.06 | 0.097 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.061 | 0.025 | 0.061 | Glycine transporter 2 inhibitor | |||
| 0.04 | 0.005 | 0.04 | Beta 1 adrenoreceptor agonist | |||
| 0.088 | 0.054 | 0.123 | Transcription factor NF kappa B stimulant | 0.123 0.024 CID_154699721 | CID_154699721 | |
| 0.094 | 0.062 | 0.094 | Prolactin inhibitor | |||
| 0.115 | 0.083 | 0.214 | Cyclooxygenase 3 inhibitor | 0.214 0.014 CID_154699721 | CID_154699721 | |
| 0.088 | 0.056 | 0.088 | Histamine antagonist | |||
| 0.036 | 0.005 | 0.036 | 1,3-Beta-glucan synthase inhibitor | 0.036 0.005 CID_154699721 | ||
| 0.043 | 0.012 | 0.043 | Glucagon receptor antagonist | |||
| 0.135 | 0.105 | 0.158 | Melanin inhibitor | 0.158 0.072 CID_154699721 | CID_154699721 | |
| 0.129 | 0.102 | 0.129 | Phospholipase A2 inhibitor | 0.126 0.107 CID_154699721 | ||
| 0.079 | 0.053 | 0.079 | Somatostatin 1 agonist | |||
| 0.101 | 0.075 | 0.101 | Nav1.4 sodium channel blocker | |||
| 0.068 | 0.042 | 0.075 | Leukotriene antagonist | 0.075 0.035 CID_154699721 | CID_154699721 | |
| 0.07 | 0.046 | 0.07 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.062 | 0.038 | 0.062 | Carbonic anhydrase stimulant | |||
| 0.049 | 0.026 | 0.049 | NMDA receptor subunit 3B antagonist | |||
| 0.06 | 0.036 | 0.06 | Alpha 1 adrenoreceptor agonist | |||
| 0.057 | 0.035 | 0.057 | Glucosylceramidase inhibitor | |||
| 0.182 | 0.16 | 0.182 | Lipoxygenase inhibitor | |||
| 0.134 | 0.113 | 0.345 | Nitric oxide antagonist | 0.345 0.032 CID_154699721 | CID_154699721 | |
| 0.052 | 0.031 | 0.052 | Squalene epoxidase inhibitor | 0.051 0.032 CID_154699721 | ||
| 0.056 | 0.036 | 0.056 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.08 | 0.061 | 0.08 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.068 | 0.049 | 0.131 | Phosphofructokinase-1 inhibitor | 0.131 0.022 CID_154699721 | CID_154699721 | |
| 0.109 | 0.091 | 0.109 | Acetylcholinesterase inhibitor | |||
| 0.065 | 0.049 | 0.065 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.071 | 0.055 | 0.071 | Glutamate dehydrogenase inhibitor | |||
| 0.108 | 0.093 | 0.108 | Toll-Like receptor 2 antagonist | |||
| 0.053 | 0.039 | 0.072 | Leukotriene B4 antagonist | 0.072 0.019 CID_154699721 | CID_154699721 | |
| 0.04 | 0.025 | 0.04 | NMDA receptor subunit 3A antagonist | |||
| 0.029 | 0.017 | 0.029 | Estrogen-related receptor gamma antagonist | |||
| 0.025 | 0.013 | 0.029 | Leukotriene B4 receptor 2 antagonist | 0.029 0.009 CID_154699721 | CID_154699721 | |
| 0.098 | 0.087 | 0.098 | Electron transport complex I inhibitor | |||
| 0.071 | 0.06 | 0.071 | Vanilloid 4 agonist | |||
| 0.021 | 0.01 | 0.021 | Alpha 2c adrenoreceptor agonist | |||
| 0.033 | 0.023 | 0.033 | Melatonin receptor 1A agonist | |||
| 0.087 | 0.077 | 0.161 | UDP-glucose 4-epimerase inhibitor | 0.161 0.025 CID_154699721 | CID_154699721 | |
| 0.094 | 0.084 | 0.094 | 5 Hydroxytryptamine antagonist | |||
| 0.1 | 0.09 | 0.102 | Photosensitizer | 0.102 0.085 CID_154699721 | CID_154699721 | |
| 0.021 | 0.011 | 0.021 | Factor IX inhibitor | |||
| 0.014 | 0.006 | 0.014 | Beta 3 adrenoreceptor agonist | |||
| 0.047 | 0.04 | 0.047 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.019 | 0.013 | 0.019 | Alpha 2b adrenoreceptor agonist | |||
| 0.086 | 0.08 | 0.086 | Carbonic anhydrase III inhibitor | |||
| 0.039 | 0.033 | 0.039 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.134 | 0.128 | 0.379 | Hepatoprotectant | 0.379 0.015 CID_154699721 | CID_154699721 | |
| 0.138 | 0.133 | 0.282 | Non-steroidal antiinflammatory agent | 0.282 0.032 CID_154699721 | CID_154699721 | |
| 0.065 | 0.061 | 0.065 | Cathepsin G inhibitor | |||
| 0.079 | 0.076 | 0.176 | NADH dehydrogenase inhibitor | 0.176 0.013 CID_154699721 | CID_154699721 | |
| 0.024 | 0.02 | 0.024 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.024 | 0.021 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 CID_154699721 | CID_154699721 | |
| 0.107 | 0.104 | 0.111 | Antibacterial (Helicobacter pylori) | 0.111 0.096 CID_154699721 | CID_154699721 | |
| 0.033 | 0.03 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 CID_154699721 | CID_154699721 | |
| 0.016 | 0.014 | 0.016 | Alpha 2a adrenoreceptor agonist | |||
| 0.138 | 0.136 | 0.138 | Succinate dehydrogenase inhibitor | |||
| 0.061 | 0.06 | 0.061 | Alpha 1b adrenoreceptor antagonist | |||
| 0.024 | 0.023 | 0.024 | Acid ceramidase inhibitor | |||
| 0.242 | 0.24 | 0.242 | 5 Hydroxytryptamine release inhibitor | |||
| 0.039 | 0.038 | 0.039 | Sphingosine 1-phosphate receptor agonist | |||
| 0.05 | 0.049 | 0.05 | Epithelial sodium channel blocker | |||
| 0.022 | 0.025 | 0.024 | Leukotriene B4 receptor 1 antagonist | 0.024 0.023 CID_154699721 | CID_154699721 | |
| 0.042 | 0.046 | 0.052 | Glucose-6-phosphate isomerase inhibitor | 0.052 0.027 CID_154699721 | CID_154699721 | |
| 0.052 | 0.057 | 0.336 | Selectin antagonist | 0.336 0.004 CID_154699721 | CID_154699721 | |
| 0.013 | 0.018 | 0.021 | Ileal bile acid transport inhibitor | 0.021 0.009 CID_154699721 | CID_154699721 | |
| 0.094 | 0.103 | 0.206 | Amylase inhibitor | 0.206 0.042 CID_154699721 | CID_154699721 | |
| 0.06 | 0.07 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.033 CID_154699721 | CID_154699721 | |
| 0.104 | 0.114 | 0.187 | DNA repair enzyme inhibitor | 0.187 0.011 CID_154699721 | CID_154699721 | |
| 0.093 | 0.104 | 0.156 | Microtubule formation inhibitor | 0.156 0.035 CID_154699721 | CID_154699721 | |
| 0.015 | 0.03 | 0.031 | Antibiotic Anthracycline-like | 0.031 0.003 CID_154699721 | CID_154699721 | |
| 0.149 | 0.167 | 0.487 | Antioxidant | 0.487 0.021 CID_154699721 | CID_154699721 | |
| 0.019 | 0.039 | 0.046 | Sodium/glucose cotransporter 2 inhibitor | 0.046 0.007 CID_154699721 | CID_154699721 | |
| 0.02 | 0.041 | 0.041 | Sodium/glucose cotransporter inhibitor | 0.041 0.007 CID_154699721 | CID_154699721 | |
| 0.215 | 0.255 | 0.502 | Apoptosis agonist | 0.502 0.074 CID_154699721 | CID_154699721 | |
| 0.013 | 0.066 | 0.042 | Protein 30S ribosomal subunit inhibitor | 0.042 0.009 CID_154699721 | CID_154699721 | |
| 0.107 | 0.173 | 0.168 | Interferon gamma antagonist | 0.168 0.058 CID_154699721 | CID_154699721 | |
| 0.064 | 0.149 | 0.133 | DNA polymerase I inhibitor | 0.133 0.059 CID_154699721 | CID_154699721 | |
| 0.032 | 0.117 | 0.139 | Antineoplastic antibiotic | 0.139 0.033 CID_154699721 | CID_154699721 | |
| 0.024 | 0.112 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.029 CID_154699721 | CID_154699721 | |
| 0.161 | 0.249 | 0.378 | Apoptosis antagonist | 0.378 0.045 CID_154699721 | CID_154699721 | |
| 0.045 | 0.141 | 0.123 | Monophenol monooxygenase inhibitor | 0.123 0.06 CID_154699721 | CID_154699721 | |
| 0.03 | 0.127 | 0.066 | Nitric oxide donor | 0.066 0.039 CID_154699721 | CID_154699721 | |
| 0.023 | 0.122 | 0.097 | Protein 50S ribosomal subunit inhibitor | 0.097 0.014 CID_154699721 | CID_154699721 | |
| 0.048 | 0.148 | 0.162 | Topoisomerase I inhibitor | 0.162 0.037 CID_154699721 | CID_154699721 | |
| 0.093 | 0.194 | 0.356 | Hemostatic | 0.356 0.011 CID_154699721 | CID_154699721 | |
| 0.107 | 0.215 | 0.173 | ATPase inhibitor | 0.173 0.067 CID_154699721 | CID_154699721 | |
| 0.053 | 0.163 | 0.091 | ATPase (Vacuolar H+) inhibitor | 0.091 0.054 CID_154699721 | CID_154699721 | |
| 0.065 | 0.179 | 0.098 | Phosphodiesterase 6D inhibitor | 0.098 0.056 CID_154699721 | CID_154699721 | |
| 0.047 | 0.166 | 0.148 | Mediator release inhibitor | 0.148 0.029 CID_154699721 | CID_154699721 | |
| 0.071 | 0.195 | 0.142 | Interleukin 4 antagonist | 0.142 0.057 CID_154699721 | CID_154699721 | |
| 0.142 | 0.267 | 0.455 | Immunosuppressant | 0.455 0.045 CID_154699721 | CID_154699721 | |
| 0.049 | 0.176 | 0.11 | Uric acid excretion stimulant | 0.11 0.044 CID_154699721 | CID_154699721 | |
| 0.022 | 0.154 | 0.043 | Microtubule stabilization | 0.043 0.038 CID_154699721 | CID_154699721 | |
| 0.061 | 0.195 | 0.213 | Lipid peroxidase inhibitor | 0.213 0.037 CID_154699721 | CID_154699721 | |
| 0.039 | 0.178 | 0.083 | Glycine receptor antagonist | 0.083 0.051 CID_154699721 | CID_154699721 | |
| 0.198 | 0.337 | 0.654 | Antiinflammatory | 0.654 0.04 CID_154699721 | CID_154699721 | |
| 0.028 | 0.17 | 0.074 | Neuraminidase (influenza) inhibitor | 0.074 0.03 CID_154699721 | CID_154699721 | |
| 0.016 | 0.164 | 0.033 | Toll-Like receptor 4 agonist | 0.033 0.009 CID_154699721 | CID_154699721 | |
| 0.018 | 0.167 | 0.064 | Neuraminidase inhibitor | 0.064 0.039 CID_154699721 | CID_154699721 | |
| 0.051 | 0.205 | 0.094 | Xanthine oxidase inhibitor | 0.094 0.065 CID_154699721 | CID_154699721 | |
| 0.148 | 0.303 | 0.572 | Antibacterial | 0.572 0.024 CID_154699721 | CID_154699721 | |
| 0.03 | 0.189 | 0.099 | Topoisomerase II alpha inhibitor | 0.099 0.04 CID_154699721 | CID_154699721 | |
| 0.089 | 0.252 | 0.428 | Free radical scavenger | 0.428 0.025 CID_154699721 | CID_154699721 | |
| 0.14 | 0.304 | 0.279 | Caspase 3 stimulant | 0.279 0.09 CID_154699721 | CID_154699721 | |
| 0.025 | 0.196 | 0.083 | Heparanase inhibitor | 0.083 0.006 CID_154699721 | CID_154699721 | |
| 0.037 | 0.213 | 0.057 | Lipocortins synthesis agonist | 0.057 0.043 CID_154699721 | CID_154699721 | |
| 0.03 | 0.226 | 0.103 | Protein-tyrosine phosphatase 1B inhibitor | 0.103 0.075 CID_154699721 | CID_154699721 | |
| 0.075 | 0.282 | 0.246 | Platelet antagonist | 0.246 0.074 CID_154699721 | CID_154699721 | |
| 0.05 | 0.26 | 0.166 | Toll-Like receptor 4 antagonist | 0.166 0.014 CID_154699721 | CID_154699721 | |
| 0.022 | 0.241 | 0.054 | Glucose-6-phosphate translocase inhibitor | 0.054 0.032 CID_154699721 | CID_154699721 | |
| 0.034 | 0.258 | 0.125 | Topoisomerase II inhibitor | 0.125 0.063 CID_154699721 | CID_154699721 | |
| 0.04 | 0.268 | 0.149 | AMP-activated protein kinase stimulant | 0.149 0.029 CID_154699721 | CID_154699721 | |
| 0.052 | 0.289 | 0.203 | Anticoagulant | 0.203 0.052 CID_154699721 | CID_154699721 | |
| 0.069 | 0.307 | 0.198 | Insulin secretagoues | 0.198 0.037 CID_154699721 | CID_154699721 | |
| 0.057 | 0.342 | 0.33 | Platelet adhesion inhibitor | 0.33 0.025 CID_154699721 | CID_154699721 | |
| 0.032 | 0.345 | 0.219 | Thrombolytic | 0.219 0.043 CID_154699721 | CID_154699721 | |
| 0.049 | 0.414 | 0.368 | Tumour necrosis factor alpha release inhibitor | 0.368 0.033 CID_154699721 | CID_154699721 | |
| 0.025 | 0.417 | 0.106 | Beta glucuronidase inhibitor | 0.106 0.062 CID_154699721 | CID_154699721 | |
| 0.046 | 0.447 | 0.23 | Alpha-glucosidase inhibitor | 0.23 0.199 CID_154699721 | CID_154699721 | |
| 0.033 | 0.447 | 0.163 | Cell adhesion inhibitor | 0.163 0.039 CID_154699721 | CID_154699721 | |
| 0.066 | 0.496 | 0.347 | Immunomodulator | 0.347 0.06 CID_154699721 | CID_154699721 | |
| 0.018 | 0.477 | 0.087 | Cell adhesion molecule inhibitor | 0.087 0.045 CID_154699721 | CID_154699721 | |
| 0.074 | 0.626 | 0.125 | CC chemokine 6 receptor antagonist | 0.125 0.092 CID_154699721 | CID_154699721 | |
| 0.031 | 0.738 | 0.161 | NOS3 expression enhancer | 0.161 0.063 CID_154699721 | CID_154699721 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |